MANE · Veradermics, Inc · Proposed Sales
$119.52
-4.87 (-3.92%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$5.04B
Shares
42.20M
Volume · Nov 20
375.02K
Avg daily vol (3M)
733.5K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-11-12 | Longitude Venture Partners V, L.P. | 10% Stockholder | 250,000 | 2026-11-11 | Goldman Sachs & Co. |
| 2026-08-19 | Averill Master Fund, Ltd. | Affiliate | 690,601 | 2026-08-19 | BofA Securities, Inc. |
| 2026-08-19 | Averill Madison Master Fund, Ltd. | Affiliate | 59,399 | 2026-08-19 | BofA Securities, Inc. |
Showing 1–3 of 3 filings
Key facts
CIK
1827635
CUSIP
922967104
13F (30d)
200 filings
197 filers
Visit website
Investor relations